1. Academic Validation
  2. Cutting edge: anti-CD1 monoclonal antibody treatment reverses the production patterns of TGF-beta 2 and Th1 cytokines and ameliorates listeriosis in mice

Cutting edge: anti-CD1 monoclonal antibody treatment reverses the production patterns of TGF-beta 2 and Th1 cytokines and ameliorates listeriosis in mice

  • J Immunol. 1999 Jun 15;162(12):6955-8.
G Szalay 1 C H Ladel C Blum L Brossay M Kronenberg S H Kaufmann
Affiliations

Affiliation

  • 1 Max Planck Institute for Infection Biology, Berlin, Germany.
PMID: 10358132
Abstract

Protection against intracellular bacteria by T cells is regulated by Ag-presenting molecules, which comprise classical MHC class I molecules, MHC class II molecules, and nonclassical MHC class Ib molecules. The role of CD1 molecules, which are structurally similar to classical MHC class I gene products, but less polymorphic, is not understood so far. We show that CD1 surface expression increased on APC in Listeria-infected mice. The in vivo treatment with anti-CD1 mAb reduced TGF-beta 2 levels and concomitantly increased secretion of the proinflammatory cytokine TNF, the Th1 cell promoting cytokine IL-12, and the Th1 cell cytokine IFN-gamma at the onset of listerial Infection. These findings point to a regulatory role of CD1-reactive cells in the immune response against listeriosis.

Figures
Products